Skip Navigation



Human Molecular Genetics Advance Access published online on December 20, 2005

Human Molecular Genetics, doi:10.1093/hmg/ddi454
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
15/2/363    most recent
ddi454v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Stuart, G. R.
Right arrow Articles by Copeland, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stuart, G. R.
Right arrow Articles by Copeland, W. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved
Received October 28, 2005
Revised December 9, 2005
Accepted December 9, 2005

Article

Mitochondrial and nuclear DNA defects in Saccharomyces cerevisiae with mutations in DNA polymerase {gamma} associated with progressive external ophthalmoplegia

Gregory R. Stuart 1, Janine H. Santos 2, Micheline K. Strand 2, Bennett Van Houten 2, and William C. Copeland 2 *

1 Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710
2 Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709

* To whom correspondence should be addressed.
William C. Copeland, E-mail: copelan1{at}niehs.nih.gov


   Abstract

A number of nuclear mutations have been identified in a variety of mitochondrial diseases including progressive external ophthalmoplegia (PEO), Alpers syndrome, and other neuromuscular and oxidative phosphorylation defects. More than fifty mutations have been identified in POLG, which encodes the human mitochondrial DNA polymerase {gamma}, in PEO and Alpers patients. To rapidly characterize the effects of these mutations, we have developed a versatile system that enables the consequences of homologous mutations, introduced in situ into the yeast mitochondrial DNA polymerase gene MIP1, to be evaluated in vivo in haploid and diploid cells. Overall, distinct phenotypes for expression of each of the mip1-PEO mutations were observed, including respiration-defective cells with decreased viability, dominant-negative mutant polymerases, elevated levels of mitochondrial and nuclear DNA damage, and chromosomal mutations. Mutations in the polymerase domain caused the most severe phenotype accompanied by loss of mitochondrial DNA and cell viability, while the mutation in the exonuclease domain showed mild dominance with loss of mitochondrial DNA. Interestingly, the linker region mutation caused elevated mitochondrial and nuclear DNA damage. The cellular processes contributing to these observations in the mutant yeast cells are potentially relevant to understanding the pathologies observed in human mitochondrial disease patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
P. Goffrini, T. Ercolino, E. Panizza, V. Giache, L. Cavone, A. Chiarugi, V. Dima, I. Ferrero, and M. Mannelli
Functional study in a yeast model of a novel succinate dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor
Hum. Mol. Genet., May 15, 2009; 18(10): 1860 - 1868.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. R. Stuart, W. C. Copeland, and M. K. Strand
Construction and application of a protein and genetic interaction network (yeast interactome)
Nucleic Acids Res., April 1, 2009; 37(7): e54 - e54.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Ashley, A. O'Rourke, C. Smith, S. Adams, V. Gowda, M. Zeviani, G. K. Brown, C. Fratter, and J. Poulton
Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations
Hum. Mol. Genet., August 15, 2008; 17(16): 2496 - 2506.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Z. F. Pursell, J. T. McDonald, C. K. Mathews, and T. A. Kunkel
Trace amounts of 8-oxo-dGTP in mitochondrial dNTP pools reduce DNA polymerase {gamma} replication fidelity
Nucleic Acids Res., April 1, 2008; 36(7): 2174 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. A. Graziewicz, R. J. Bienstock, and W. C. Copeland
The DNA polymerase {gamma} Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine
Hum. Mol. Genet., November 15, 2007; 16(22): 2729 - 2739.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
E. Baruffini, T. Lodi, C. Dallabona, and F. Foury
A Single Nucleotide Polymorphism in the DNA Polymerase Gamma Gene of Saccharomyces cerevisiae Laboratory Strains Is Responsible for Increased Mitochondrial DNA Mutability
Genetics, October 1, 2007; 177(2): 1227 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Hudson, A. M. Schaefer, R. W. Taylor, W. Tiangyou, A. Gibson, G. Venables, P. Griffiths, D. J. Burn, D. M. Turnbull, and P. F. Chinnery
Mutation of the Linker Region of the Polymerase {gamma}-1 (POLG1) Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism
Arch Neurol, April 1, 2007; 64(4): 553 - 557.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Baruffini, T. Lodi, C. Dallabona, A. Puglisi, M. Zeviani, and I. Ferrero
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans
Hum. Mol. Genet., October 1, 2006; 15(19): 2846 - 2855.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.